Compare Abbott India with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DIVIS LABORATORIES ABBOTT INDIA/
DIVIS LABORATORIES
 
P/E (TTM) x 48.2 32.4 148.8% View Chart
P/BV x 15.1 10.3 145.9% View Chart
Dividend Yield % 1.5 0.6 274.1%  

Financials

 ABBOTT INDIA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-21
DIVIS LABORATORIES
Mar-21
ABBOTT INDIA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs18,5693,913 474.5%   
Low Rs13,9701,824 765.8%   
Sales per share (Unadj.) Rs2,028.2262.5 772.6%  
Earnings per share (Unadj.) Rs325.074.7 434.8%  
Cash flow per share (Unadj.) Rs352.484.4 417.6%  
Dividends per share (Unadj.) Rs275.0020.00 1,375.0%  
Avg Dividend yield %1.70.7 242.4%  
Book value per share (Unadj.) Rs1,203.7350.1 343.8%  
Shares outstanding (eoy) m21.25265.47 8.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.010.9 73.4%   
Avg P/E ratio x50.138.4 130.4%  
P/CF ratio (eoy) x46.234.0 135.8%  
Price / Book Value ratio x13.58.2 165.0%  
Dividend payout %84.626.8 316.2%   
Avg Mkt Cap Rs m345,717761,517 45.4%   
No. of employees `000NANA-   
Total wages/salary Rs m4,9278,258 59.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m43,10069,694 61.8%  
Other income Rs m835627 133.2%   
Total revenues Rs m43,93570,321 62.5%   
Gross profit Rs m9,18928,611 32.1%  
Depreciation Rs m5812,556 22.7%   
Interest Rs m18321 870.5%   
Profit before tax Rs m9,26026,660 34.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3536,818 34.5%   
Profit after tax Rs m6,90719,843 34.8%  
Gross profit margin %21.341.1 51.9%  
Effective tax rate %25.425.6 99.4%   
Net profit margin %16.028.5 56.3%  
BALANCE SHEET DATA
Current assets Rs m35,18567,906 51.8%   
Current liabilities Rs m10,30917,284 59.6%   
Net working cap to sales %57.772.6 79.5%  
Current ratio x3.43.9 86.9%  
Inventory Days Days410 46.9%  
Debtors Days Days2878 0.2%  
Net fixed assets Rs m3,04145,963 6.6%   
Share capital Rs m213531 40.0%   
"Free" reserves Rs m25,36692,415 27.4%   
Net worth Rs m25,57992,946 27.5%   
Long term debt Rs m00-   
Total assets Rs m38,226113,869 33.6%  
Interest coverage x51.71,270.5 4.1%   
Debt to equity ratio x00-  
Sales to assets ratio x1.10.6 184.2%   
Return on assets %18.517.4 106.3%  
Return on equity %27.021.3 126.5%  
Return on capital %36.928.7 128.6%  
Exports to sales %0.70-   
Imports to sales %12.318.8 65.4%   
Exports (fob) Rs m295NA-   
Imports (cif) Rs m5,30613,127 40.4%   
Fx inflow Rs m35358,877 0.6%   
Fx outflow Rs m5,38913,341 40.4%   
Net fx Rs m-5,03545,536 -11.1%   
CASH FLOW
From Operations Rs m7,26719,469 37.3%  
From Investments Rs m-718751 -95.6%  
From Financial Activity Rs m-5,818-349 1,667.5%  
Net Cashflow Rs m73119,872 3.7%  

Share Holding

Indian Promoters % 0.0 51.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.7 36.8 21.0%  
FIIs % 0.2 18.5 1.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.1 52.0%  
Shareholders   90,567 309,397 29.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    

Yellow Ad

Advertisement

How to Find One Stock with Crorepati Potential?

There are three critical characteristics that differentiate a common stock from a potential 'crorepati' stock.

And we are going to reveal them during our 'One Stock Crorepati' MEGA summit on 30th June.

If you are interested in finding a potential 'crorepati' stock, don't miss this.

At this MEGA Summit we will reveal details of what we call a 'crorepati' stock...

You just cannot afford to miss this summit for anything.

Learn more



Today's Market

SGX Nifty Down 158 Points, Tata Motors' Price Hike, Ruchi Soya Becomes Patanjali Foods, and Top Buzzing Stocks Today(Pre-Open)

On Tuesday, Indian share markets witnessed a volatile trading session as crude oil prices rebounded following last week's rout.

Related Views on News

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

When Will the Stock Market Recover?(Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jun 28, 2022 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - AVON ORGANIC COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS